Skip to main content
Anita Kohli, MD, Ophthalmology, New Haven, CT

AnitaA.KohliMD

Ophthalmology • New Haven, CT

Neuro-Ophthalmology, Pediatric & Strabismus

Yale Departments of Ophthalmology & Visual Science and Neurology

Join to view full profile

Dr. Kohli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kohli's full profile

Already have an account?

  • Office

    40 Temple St
    Ste 1B
    New Haven, CT 06510
    Phone+1 203-785-3360

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Neuro-Ophthalmology, 2016 - 2017
  • University of Pennsylvania Health System/Scheie Eye Institute
    University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 2013 - 2016
  • University of Maryland
    University of MarylandInternship, Internal Medicine, 2012 - 2013
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2012

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2017 - 2024
  • PA State Medical License
    PA State Medical License 2013 - 2018
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society, 2011

Publications & Presentations

PubMed

Press Mentions

  • PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024
    PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024
  • PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024
    PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024October 16th, 2024

Professional Memberships

Dr. Anita Kohli, Dr. Anita Kohli, MD, Dr. A Kohli, Dr. Anita A. Kohli